FTC Amicus Brief: Improper Use of Restricted Drug Distribution Programs May Impede Generic Competition
Date
The Federal Trade Commission has filed an amicus brief in the U.S. District Court for the District of New Jersey explaining that a brand name drug manufacturer’s improper use of a restricted drug...